From: National Geographic
How COVID-19 is Changing Our Expectations for Other Vaccines
As scientists raced to create new vaccines that would fight the novel coronavirus, Matthew Motta had a question: What did Americans expect from these vaccines?
Motta, a political scientist at Oklahoma State University who studies vaccine hesitancy, polled nearly 1,000 American adults on their expectations for the then-hypothetical shots. His peer-reviewed study, published this March in Social Science & Medicine, uncovered what he described as predictable results: Given the choice between various efficacy rates and single or multi-dose shots, the vaccine Americans would most prefer was a single dose that boasted at least 90 percent efficacy and almost zero chance of causing even minor side effects.
Read the whole story (subscription may be required): National Geographic
More of our Members in the Media >
APS regularly opens certain online articles for discussion on our website. Effective February 2021, you must be a logged-in APS member to post comments. By posting a comment, you agree to our Community Guidelines and the display of your profile information, including your name and affiliation. Any opinions, findings, conclusions, or recommendations present in article comments are those of the writers and do not necessarily reflect the views of APS or the article’s author. For more information, please see our Community Guidelines.
Please login with your APS account to comment.